GB Capital Ltd. Co-Advises on the Acquisition of A&B Aerospace Inc.
May 18, 2026
Alzheimer’s Patients Treated with INmune Bio’s XPro(TM) Show Reduction in CSF Phospho-Tau and Evidence of Remyelination
September 1, 2021
Related Post
-
-
Quince Announces Acquisition of Orphai and up to $187 Million Private Placement to Advance Pulmonary Pipeline
May 18, 2026
-
Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 15, 2026
-
BioXcel Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
May 15, 2026